Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.
Administrative law and regulatory proceduresAdministrative remediesBusiness ethicsCanadaCivil actions and liabilityCompetition and antitrustDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFederal Trade Commission (FTC)Food and Drug Administration (FDA)Government information and archivesHealth care costs and insuranceHealth information and medical recordsInflation and pricesIntellectual propertyLicensing and registrationsManufacturingMedicarePrescription drugsPublic participation and lobbyingTrade restrictions
Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020
USA116th CongressS-3384| Senate
| Updated: 3/3/2020
Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.
Administrative law and regulatory proceduresAdministrative remediesBusiness ethicsCanadaCivil actions and liabilityCompetition and antitrustDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFederal Trade Commission (FTC)Food and Drug Administration (FDA)Government information and archivesHealth care costs and insuranceHealth information and medical recordsInflation and pricesIntellectual propertyLicensing and registrationsManufacturingMedicarePrescription drugsPublic participation and lobbyingTrade restrictions